{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T04:03:10Z","timestamp":1773028990760,"version":"3.50.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.vaccine.2008.11.087","type":"journal-article","created":{"date-parts":[[2008,12,13]],"date-time":"2008-12-13T09:02:54Z","timestamp":1229158974000},"page":"893-903","source":"Crossref","is-referenced-by-count":36,"title":["Recombinant vesicular stomatitis virus-based west Nile vaccine elicits strong humoral and cellular immune responses and protects mice against lethal challenge with the virulent west Nile virus strain LSU-AR01"],"prefix":"10.1016","volume":"27","author":[{"given":"Arun V.","family":"Iyer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bapi","family":"Pahar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc J.","family":"Boudreaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuko","family":"Wakamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alma F.","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladimir N.","family":"Chouljenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abolghasem","family":"Baghian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristian","family":"Apetrei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Preston A.","family":"Marx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin G.","family":"Kousoulas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.11.087_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4269\/ajtmh.1940.s1-20.471","article-title":"A neurotropic virus isolated from the blood of a native of Uganda","volume":"20","author":"Smithburn","year":"1940","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2008.11.087_bib2","series-title":"Fields\u2019 virology","first-page":"1101","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2007"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2008.11.087_bib3","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/emboj\/cdg270","article-title":"Structures of immature flavivirus particles","volume":"22","author":"Zhang","year":"2003","journal-title":"Embo J"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2008.11.087_bib4","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.str.2004.06.019","article-title":"Conformational changes of the flavivirus E glycoprotein","volume":"12","author":"Zhang","year":"2004","journal-title":"Structure"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2008.11.087_bib5","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1086\/523654","article-title":"Antibodies targeting linear determinants of the envelope protein protect mice against West Nile virus","volume":"196","author":"Ledizet","year":"2007","journal-title":"J Infect Dis"},{"issue":"December (5448)","key":"10.1016\/j.vaccine.2008.11.087_bib6","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","article-title":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States","volume":"286","author":"Lanciotti","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2008.11.087_bib7","unstructured":"CDC. Intrauterine West Nile virus infection--New York, 2002. MMWR Morb Mortal Wkly Rep 2002;51(December (50)):1135\u20136."},{"key":"10.1016\/j.vaccine.2008.11.087_bib8","unstructured":"CDC. Possible West Nile virus transmission to an infant through breast-feeding--Michigan, 2002. MMWR Morb Mortal Wkly Rep 2002;51(October (39)):877\u20138."},{"issue":"May (5)","key":"10.1016\/j.vaccine.2008.11.087_bib9","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1542\/peds.113.5.1375","article-title":"West Nile virus infection: a pediatric perspective","volume":"113","author":"Hayes","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2008.11.087_bib10","unstructured":"CDC. Transfusion-associated transmission of West Nile virus--Arizona, 2004. MMWR Morb Mortal Wkly Rep 2004;53(September (36)):842\u20134."},{"key":"10.1016\/j.vaccine.2008.11.087_bib11","unstructured":"CDC. Investigations of West Nile virus infections in recipients of blood transfusions. MMWR Morb Mortal Wkly Rep 2002;51(November (43)):973\u20134."},{"key":"10.1016\/j.vaccine.2008.11.087_bib12","unstructured":"CDC. Detection of West Nile virus in blood donations--United States, 2003. MMWR Morb Mortal Wkly Rep 2003;52(August (32)):769\u201372."},{"issue":"November (9)","key":"10.1016\/j.vaccine.2008.11.087_bib13","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1086\/378891","article-title":"A fatal case of West Nile virus infection in a bone marrow transplant recipient","volume":"37","author":"Hiatt","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2008.11.087_bib14","unstructured":"CDC. West Nile virus infection in organ donor and transplant recipients--Georgia and Florida, 2002. MMWR Morb Mortal Wkly Rep 2002;51(September (35)):790."},{"issue":"May (22)","key":"10.1016\/j.vaccine.2008.11.087_bib15","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1056\/NEJMoa022987","article-title":"Transmission of West Nile virus from an organ donor to four transplant recipients","volume":"348","author":"Iwamoto","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2008.11.087_bib16","unstructured":"CDC. Possible dialysis-related west nile virus transmission--Georgia, 2003. MMWR Morb Mortal Wkly Rep 2004;53(August (32)):738\u20139."},{"issue":"November (12)","key":"10.1016\/j.vaccine.2008.11.087_bib17","first-page":"73","article-title":"The West Nile Virus and the dialysis\/transplant patient","volume":"19","author":"Cairoli","year":"2005","journal-title":"Nephrol News Issues"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2008.11.087_bib18","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-140-7-200404060-00015","article-title":"West Nile virus: pathogenesis and therapeutic options","volume":"140","author":"Gea-Banacloche","year":"2004","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.vaccine.2008.11.087_bib19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1159\/000088506","article-title":"Skin manifestations of West Nile virus infection","volume":"211","author":"Del Giudice","year":"2005","journal-title":"Dermatology"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2008.11.087_bib20","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1086\/444506","article-title":"Characteristics of the rash associated with West Nile virus fever","volume":"41","author":"Ferguson","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2008.11.087_bib21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.20959","article-title":"West Nile virus neuroinvasive disease","volume":"60","author":"Davis","year":"2006","journal-title":"Ann Neurol"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2008.11.087_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1212\/01.WNL.0000073617.08185.0A","article-title":"West Nile virus infection: a new acute paralytic illness","volume":"61","author":"Jeha","year":"2003","journal-title":"Neurology"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2008.11.087_bib23","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1067\/mem.2003.67","article-title":"West Nile encephalitis presenting as a stroke","volume":"41","author":"Kulstad","year":"2003","journal-title":"Ann Emerg Med"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2008.11.087_bib24","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.4269\/ajtmh.1974.23.1150","article-title":"Acute pancreatitis in West Nile fever","volume":"23","author":"Perelman","year":"1974","journal-title":"Am J Trop Med Hyg"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2008.11.087_bib25","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1053\/hp.2000.8047","article-title":"The pathology of human West Nile virus infection","volume":"31","author":"Sampson","year":"2000","journal-title":"Hum Pathol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2008.11.087_bib26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.humpath.2003.09.007","article-title":"West Nile virus encephalitis with myositis and orchitis","volume":"35","author":"Smith","year":"2004","journal-title":"Hum Pathol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2008.11.087_bib27","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.ophtha.2004.03.032","article-title":"Chorioretinal involvement in patients with West Nile virus infection","volume":"111","author":"Khairallah","year":"2004","journal-title":"Ophthalmology"},{"issue":"August (8)","key":"10.1016\/j.vaccine.2008.11.087_bib28","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3201\/eid1108.050289b","article-title":"Virology, pathology, and clinical manifestations of West Nile virus disease","volume":"11","author":"Hayes","year":"2005","journal-title":"Emerg Infect Dis"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2008.11.087_bib29","first-page":"1617","article-title":"The long-term outcomes of human West Nile virus infection","volume":"44","author":"Sejvar","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"July (30)","key":"10.1016\/j.vaccine.2008.11.087_bib30","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1016\/j.vaccine.2006.12.005","article-title":"West Nile virus: recent trends in diagnosis and vaccine development","volume":"25","author":"Dauphin","year":"2007","journal-title":"Vaccine"},{"issue":"Winter (4)","key":"10.1016\/j.vaccine.2008.11.087_bib31","first-page":"251","article-title":"The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine","volume":"5","author":"Grosenbaugh","year":"2004","journal-title":"Vet Ther"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2008.11.087_bib32","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2460\/ajvr.2004.65.1459","article-title":"Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses","volume":"65","author":"Siger","year":"2004","journal-title":"Am J Vet Res"},{"issue":"18","key":"10.1016\/j.vaccine.2008.11.087_bib33","first-page":"221","article-title":"Recombinant canarypoxvirus vaccine carrying the prM\/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge","author":"Minke","year":"2004","journal-title":"Arch Virol Suppl"},{"issue":"May (29)","key":"10.1016\/j.vaccine.2008.11.087_bib34","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1016\/j.vaccine.2005.02.020","article-title":"Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge","volume":"23","author":"Karaca","year":"2005","journal-title":"Vaccine"},{"issue":"Fall (3)","key":"10.1016\/j.vaccine.2008.11.087_bib35","first-page":"249","article-title":"Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses","volume":"7","author":"Siger","year":"2006","journal-title":"Vet Ther"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2008.11.087_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jgm.837","article-title":"A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus","volume":"8","author":"Iglesias","year":"2006","journal-title":"J Gene Med"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2008.11.087_bib37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1086\/426824","article-title":"Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis","volume":"191","author":"Despres","year":"2005","journal-title":"J Infect Dis"},{"issue":"August (1)","key":"10.1016\/j.vaccine.2008.11.087_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1473-3099(01)00016-0","article-title":"Yellow fever: an update","volume":"1","author":"Monath","year":"2001","journal-title":"Lancet Infect Dis"},{"issue":"December","key":"10.1016\/j.vaccine.2008.11.087_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2001.tb02680.x","article-title":"Prospects for development of a vaccine against the West Nile virus","volume":"951","author":"Monath","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2008.11.087_bib40","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3201\/eid0812.020229","article-title":"Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2008.11.087_bib41","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J Virol"},{"issue":"April (17)","key":"10.1016\/j.vaccine.2008.11.087_bib42","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2008.11.087_bib43","first-page":"498","article-title":"ChimeriVax-West Nile vaccine","volume":"9","author":"Hall","year":"2007","journal-title":"Curr Opin Mol Ther"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2008.11.087_bib44","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.molmed.2004.03.003","article-title":"Vesicular stomatitis virus: re-inventing the bullet","volume":"10","author":"Lichty","year":"2004","journal-title":"Trends Mol Med"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2008.11.087_bib45","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1128\/JVI.72.6.4704-4711.1998","article-title":"Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge","volume":"72","author":"Roberts","year":"1998","journal-title":"J Virol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2008.11.087_bib46","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.73.5.3723-3732.1999","article-title":"Attenuated vesicular stomatitis viruses as vaccine vectors","volume":"73","author":"Roberts","year":"1999","journal-title":"J Virol"},{"issue":"September (1)","key":"10.1016\/j.vaccine.2008.11.087_bib47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.virol.2007.04.021","article-title":"Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection","volume":"366","author":"Schwartz","year":"2007","journal-title":"Virology"},{"issue":"August (1)","key":"10.1016\/j.vaccine.2008.11.087_bib48","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0168-1702(00)00164-7","article-title":"Presence of bovine viral diarrhea virus (BVDV) E2 glycoprotein in VSV recombinant particles and induction of neutralizing BVDV antibodies in mice","volume":"69","author":"Grigera","year":"2000","journal-title":"Virus Res"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2008.11.087_bib49","doi-asserted-by":"crossref","first-page":"11079","DOI":"10.1128\/JVI.75.22.11079-11087.2001","article-title":"Replication-competent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge","volume":"75","author":"Kahn","year":"2001","journal-title":"J Virol"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2008.11.087_bib50","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.vaccine.2006.08.012","article-title":"Therapeutic efficacy of vesicular stomatitis virus-based E6 vaccination in rabbits","volume":"25","author":"Brandsma","year":"2007","journal-title":"Vaccine"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2008.11.087_bib51","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.1128\/JVI.02835-06","article-title":"Vesicular stomatitis virus-based therapeutic vaccination targeted to the E1, E2, E6, and E7 proteins of cottontail rabbit papillomavirus","volume":"81","author":"Brandsma","year":"2007","journal-title":"J Virol"},{"issue":"December (23)","key":"10.1016\/j.vaccine.2008.11.087_bib52","doi-asserted-by":"crossref","first-page":"12325","DOI":"10.1128\/JVI.76.23.12325-12334.2002","article-title":"Generation of hepatitis C virus-like particles by use of a recombinant vesicular stomatitis virus vector","volume":"76","author":"Ezelle","year":"2002","journal-title":"J Virol"},{"issue":"August (Pt 8)","key":"10.1016\/j.vaccine.2008.11.087_bib53","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1099\/vir.0.19050-0","article-title":"Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose","volume":"84","author":"Schlereth","year":"2003","journal-title":"J Gen Virol"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2008.11.087_bib54","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J Virol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2008.11.087_bib55","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm1258","article-title":"Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses","volume":"11","author":"Jones","year":"2005","journal-title":"Nat Med"},{"issue":"October (19)","key":"10.1016\/j.vaccine.2008.11.087_bib56","doi-asserted-by":"crossref","first-page":"9659","DOI":"10.1128\/JVI.00959-06","article-title":"Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine","volume":"80","author":"Daddario-DiCaprio","year":"2006","journal-title":"J Virol"},{"issue":"April (9520)","key":"10.1016\/j.vaccine.2008.11.087_bib57","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(06)68546-2","article-title":"Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment","volume":"367","author":"Daddario-DiCaprio","year":"2006","journal-title":"Lancet"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2008.11.087_bib58","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"Geisbert","year":"2005","journal-title":"PLoS Med"},{"issue":"September (2)","key":"10.1016\/j.vaccine.2008.11.087_bib59","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.virol.2005.06.016","article-title":"Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine","volume":"340","author":"Kapadia","year":"2005","journal-title":"Virology"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2008.11.087_bib60","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1128\/JVI.80.9.4447-4457.2006","article-title":"Recombinant vesicular stomatitis virus vectors expressing herpes simplex virus type 2 gD elicit robust CD4+ Th1 immune responses and are protective in mouse and guinea pig models of vaginal challenge","volume":"80","author":"Natuk","year":"2006","journal-title":"J Virol"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2008.11.087_bib61","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1006\/viro.1999.0120","article-title":"Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope","volume":"268","author":"Haglund","year":"2000","journal-title":"Virology"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2008.11.087_bib62","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/viro.1998.9429","article-title":"A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions","volume":"251","author":"Johnson","year":"1998","journal-title":"Virology"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2008.11.087_bib63","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/JVI.71.7.5060-5068.1997","article-title":"Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins","volume":"71","author":"Johnson","year":"1997","journal-title":"J Virol"},{"issue":"May\u2013July (3\u20134)","key":"10.1016\/j.vaccine.2008.11.087_bib64","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tube.2006.01.017","article-title":"Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization","volume":"86","author":"Xing","year":"2006","journal-title":"Tuberculosis (Edinb)"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2008.11.087_bib65","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.vaccine.2006.08.010","article-title":"An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge","volume":"25","author":"Palin","year":"2007","journal-title":"Vaccine"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2008.11.087_bib66","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1089\/aid.2004.20.989","article-title":"Immunogenicity of attenuated vesicular stomatitis virus vectors expressing HIV type 1 Env and SIV Gag proteins: comparison of intranasal and intramuscular vaccination routes","volume":"20","author":"Egan","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"April (8)","key":"10.1016\/j.vaccine.2008.11.087_bib67","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1128\/JVI.78.8.3930-3940.2004","article-title":"Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol","volume":"78","author":"Ramsburg","year":"2004","journal-title":"J Virol"},{"issue":"September (5)","key":"10.1016\/j.vaccine.2008.11.087_bib68","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0092-8674(01)00482-2","article-title":"An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants","volume":"106","author":"Rose","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2008.11.087_bib69","unstructured":"Iyer AV, Boudreaux MJ, Wakamatsu N, Roy AF, Baghian A, Chouljenko VN, et al. The Louisiana West Nile virus strain LSU-AR01 isolated from a blue jay (Cyanocitta cristata) exhibits increased mouse neurovirulence in comparison to the prototypic New York-99 strain and is closely related to the Connecticut-99 mosquito isolate, Virus Genes, in press."},{"issue":"October (21)","key":"10.1016\/j.vaccine.2008.11.087_bib70","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1073\/pnas.93.21.11359","article-title":"Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles","volume":"93","author":"Schnell","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2008.11.087_bib71","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1128\/JVI.70.4.2318-2323.1996","article-title":"The minimal conserved transcription stop-start signal promotes stable expression of a foreign gene in vesicular stomatitis virus","volume":"70","author":"Schnell","year":"1996","journal-title":"J Virol"},{"issue":"June (1)","key":"10.1016\/j.vaccine.2008.11.087_bib72","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.virol.2007.01.010","article-title":"T cell responses in macaques acutely infected with SHIV(sf162p3)","volume":"363","author":"Pahar","year":"2007","journal-title":"Virology"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2008.11.087_bib73","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J Virol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2008.11.087_bib74","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/intimm\/5.11.1445","article-title":"Polyclonal activation of immature B cells by preactivated T cells: the role of IL-4 and CD40 ligand","volume":"5","author":"Brines","year":"1993","journal-title":"Int Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2008.11.087_bib75","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.it.2004.12.006","article-title":"CD69 is an immunoregulatory molecule induced following activation","volume":"26","author":"Sancho","year":"2005","journal-title":"Trends Immunol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2008.11.087_bib76","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1084\/jem.20060468","article-title":"Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells","volume":"203","author":"Seddiki","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2008.11.087_bib77","series-title":"Manual of diagnostic tests and vaccines for terrestrial animals 2004","article-title":"Vesicular stomatitis","author":"Office international des \u00e9pizooties (Paris)","year":"2004"},{"issue":"November (3)","key":"10.1016\/j.vaccine.2008.11.087_bib78","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00281-006-0042-3","article-title":"Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector","volume":"28","author":"Clarke","year":"2006","journal-title":"Springer seminars in immunopathology"},{"issue":"February (5813)","key":"10.1016\/j.vaccine.2008.11.087_bib79","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1135710","article-title":"Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G","volume":"315","author":"Roche","year":"2007","journal-title":"Science"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2008.11.087_bib80","doi-asserted-by":"crossref","first-page":"8900","DOI":"10.1128\/JVI.76.17.8900-8909.2002","article-title":"Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease","volume":"76","author":"Reuter","year":"2002","journal-title":"J Virol"},{"issue":"November (21)","key":"10.1016\/j.vaccine.2008.11.087_bib81","doi-asserted-by":"crossref","first-page":"13231","DOI":"10.1128\/JVI.79.21.13231-13238.2005","article-title":"A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector","volume":"79","author":"Publicover","year":"2005","journal-title":"J Virol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2008.11.087_bib82","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1128\/JVI.01515-07","article-title":"Attenuation of recombinant vesicular stomatitis virus-human immunodeficiency virus type 1 vaccine vectors by gene translocations and g gene truncation reduces neurovirulence and enhances immunogenicity in mice","volume":"82","author":"Cooper","year":"2008","journal-title":"J Virol"},{"issue":"December (23)","key":"10.1016\/j.vaccine.2008.11.087_bib83","doi-asserted-by":"crossref","first-page":"10903","DOI":"10.1128\/JVI.74.23.10903-10910.2000","article-title":"Glycoprotein exchange vectors based on vesicular stomatitis virus allow effective boosting and generation of neutralizing antibodies to a primary isolate of human immunodeficiency virus type 1","volume":"74","author":"Rose","year":"2000","journal-title":"J Virol"},{"issue":"September (5283)","key":"10.1016\/j.vaccine.2008.11.087_bib84","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1126\/science.273.5283.1864","article-title":"Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis","volume":"273","author":"Grewal","year":"1996","journal-title":"Science"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2008.11.087_bib85","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/1074-7613(94)90095-7","article-title":"The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation","volume":"1","author":"Kawabe","year":"1994","journal-title":"Immunity"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2008.11.087_bib86","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/13550280290100941","article-title":"Regulation and function of class II major histocompatibility complex, CD40, and B7 expression in macrophages and microglia: Implications in neurological diseases","volume":"8","author":"O\u2019Keefe","year":"2002","journal-title":"J Neurovirol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2008.11.087_bib87","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/eji.200737196","article-title":"Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection","volume":"37","author":"Brien","year":"2007","journal-title":"Eur J Immunol"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2008.11.087_bib88","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1073\/pnas.0711874105","article-title":"Epitope discovery in West Nile virus infection: identification and immune recognition of viral epitopes","volume":"105","author":"McMurtrey","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2008.11.087_bib89","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/eji.200737192","article-title":"Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis","volume":"37","author":"Purtha","year":"2007","journal-title":"Eur J Immunol"},{"issue":"July\u2013August (4)","key":"10.1016\/j.vaccine.2008.11.087_bib90","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3201\/eid0704.017419","article-title":"Rapid determination of HLA B*07 ligands from the West Nile virus NY99 genome","volume":"7","author":"De Groot","year":"2001","journal-title":"Emerg Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2008.11.087_bib91","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1128\/IAI.71.1.317-326.2003","article-title":"Expression of L-Selectin (CD62L), CD44, and CD25 on activated bovine T cells","volume":"71","author":"Waters","year":"2003","journal-title":"Infect Immun"},{"issue":"June (3)","key":"10.1016\/j.vaccine.2008.11.087_bib92","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/jcp.21001","article-title":"The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road","volume":"211","author":"Zhang","year":"2007","journal-title":"J Cell Physiol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2008.11.087_bib93","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.it.2006.10.002","article-title":"Cell-surface IL-7 receptor expression facilitates the purification of FOXP3(+) regulatory T cells","volume":"27","author":"Banham","year":"2006","journal-title":"Trends Immunol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2008.11.087_bib94","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1084\/jem.20060772","article-title":"CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells","volume":"203","author":"Liu","year":"2006","journal-title":"J Exp Med"},{"issue":"December (24)","key":"10.1016\/j.vaccine.2008.11.087_bib95","doi-asserted-by":"crossref","first-page":"13323","DOI":"10.1128\/JVI.77.24.13323-13334.2003","article-title":"CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis","volume":"77","author":"Wang","year":"2003","journal-title":"J Virol"},{"issue":"August (15)","key":"10.1016\/j.vaccine.2008.11.087_bib96","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1128\/JVI.78.15.8312-8321.2004","article-title":"Role of CD8+ T cells in control of West Nile virus infection","volume":"78","author":"Shrestha","year":"2004","journal-title":"J Virol"},{"issue":"July (14)","key":"10.1016\/j.vaccine.2008.11.087_bib97","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.1128\/JVI.76.14.6865-6872.2002","article-title":"Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins","volume":"76","author":"Buonocore","year":"2002","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08016356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08016356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T01:23:26Z","timestamp":1709774606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08016356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":97,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0264410X08016356"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.087","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}